Life Sciences Times

Affinia Therapeutics Clears Regulatory Milestone to Launch BAG3 Cardiomyopathy Trial in Canada

Insight Health Raises $11 Million Series A to Address Healthcare Administrative Burden

H2 Global Group Highlights MedTech Investment Gains and U.S. Expansion Plans

SV Health Investors Acquires EpiVax in Life Sciences Services Expansion

Vedanta Phase 3 Trial of VE303 Cleared to Continue After Interim Review

Seaport Therapeutics Reports Positive Phase 1 Results for GlyphAgo in Anxiety Disorder Study

PureTech Reports Positive Phase 2b Results for Deupirfenidone in Pulmonary Fibrosis Study

AstraZeneca Combo Therapy Shows Improved Progression-Free Survival in Early Liver Cancer Trial

Thermo Fisher Launches Automated System to Streamline Cell Therapy Manufacturing

Iterative Health, US Heart & Vascular Partner to Expand Community-Based Cardiovascular Research